The first doses of the Russian HPV vaccine will reach medical institutions at the end of September

The first doses of the Russian HPV vaccine will reach medical institutions at the end of September

The domestic vaccine against the human papillomavirus (HPV) "Tsegardex" produced by the company "Nanolek" was released into civilian circulation; The first dose of the drug, whose volume amounted to 30 thousand doses, will reach medical institutions at the end of September, said the CEO of Nanolac, Yevgeny Barinov. "The initial dose of 30 thousand doses has already been released into circulation, 600 thousand doses will be produced by the end of the year," said Barinov at a press conference on Tuesday, adding that the first dose of the drug will reach medical institutions at the end of September.